The company also received approval for its BrainSense Electrode Identifier (EI). Together, these technologies use a minimally invasive, surgically implanted neurostimulator to transmit electrical signals to specific parts of the brain affected by neurological disorders. They act as a sort of brain pacemaker to treat Parkinson’s disease.

BrainSense aDBS, delivered through the Medtronic Percept neurostimulator, provides real-time, adaptive therapy. It dynamically adjusts stimulation based on each person’s unique brain activity, both in clinical settings and daily life. The BrainSense EI technology can improve DBS programming by ensuring optimal initial contact selection in less time.

Percept with BrainSense technology records and analyzes brain signals to enable tailored therapy for each patient’s unique neurological patterns. Medtronic incorporates brain-computer interface (BCI) technolgoy into its DBS therapy. It aims to make advances in prevention, detection, diagnosis, rehabilitation and restoration for patients with complex neurological conditions.